(Q33359794)

English

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors

scientific article

Statements

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors (English)
Victor M Santana
Lisa C Iacono
Wayne L Furman
Dana R Hawkins
J Carl Panetta
Amar J Gajjar
Clinton F Stewart

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit